DOI:
10.1039/C4RA04427D
(Paper)
RSC Adv., 2014,
4, 31345-31352
VanadiumV(salen) catalysed synthesis of oxazolidinones from epoxides and isocyanates†
Received
12th May 2014
, Accepted 4th July 2014
First published on 4th July 2014
Abstract
The combination of a vanadiumV(salen) complex V+O(salen) EtOSO3− and tetrabutylammonium bromide forms a highly active catalyst system for the reaction between epoxides and isocyanates leading to oxazolidinones. The reaction conditions were optimized and the optimal conditions (80 °C in toluene for 5 hours with 2 mol% of vanadium catalyst and 2 mol% of tetrabutylammonium bromide cocatalyst) applied to eight epoxides and six aromatic isocyanates, giving 18 oxazolidinones with conversions of 34–98% and isolated chemical yields of the major regioisomer of 23–89%.
Introduction
The reaction of epoxides 1 with heterocumulenes can lead to a range of five-membered ring heterocycles, some of which are shown in Scheme 1. The area is currently dominated by the synthesis of cyclic carbonates 2 from epoxides and carbon dioxide,1 but the reaction of epoxides with isocyanates to form oxazolidinones 3/4 is also of significant interest as oxazolidinones are components of pharmaceuticals2 and useful synthetic intermediates.3 Catalysts based on ammonium salts,4 lanthanide salts,5 lithium halides,6 magnesium halides,7 tetraphenylantimony iodide8 and trialkyltin halides.9 have previously been reported for the synthesis of oxazolidinones from epoxides and isocyanates.10
 |
| Scheme 1 Synthesis of heterocycles using catalyst 5. | |
We have reported that bimetallic aluminium(salen) complex 511 would catalyse the formation of cyclic carbonates 2 from epoxides 1 and carbon dioxide,12 the formation of di- and tri-thiocarbonates 6 and 7 from epoxides and carbon disulphide13 and the synthesis of oxazolidinones 3/4 from epoxides and isocyanates14 (Scheme 1). Whilst complex 5 displayed high activity at room temperature for the synthesis of cyclic carbonates, it was less active for the synthesis of thiocarbonates and oxazolidinones; reactions requiring higher catalyst loadings (5 mol%) and reaction temperatures (50–90 °C). A mechanistic study15 revealed that thiocarbonate and oxazolidinone synthesis catalysed by complex 5 had higher enthalpies of activation and less negative entropies of activation than cyclic carbonate synthesis. Therefore, we aimed to develop more active catalysts for the reaction between epoxides and carbon disulphide or isocyanates based on using more Lewis acidic metals to lower the enthalpy of activation. This led to the discovery that a bimetallic titanium(salen) complex was a highly active catalyst for the synthesis of thiocarbonates16 6/7 and in this paper we report the development of a vanadiumV(salen) complex for the synthesis of oxazolidinones 3/4.
Results and discussion
VanadiumV(salen) complexes 8a–g have previously been developed as highly enantioselective catalysts for asymmetric cyanohydrin synthesis,17,18 asymmetric Strecker reactions19 and asymmetric Michael additions of cyanide to nitroalkenes.20 The catalytic activity of complexes 8a–g was found to vary significantly depending upon the nature of the counterion with the highest catalytic activity observed with the least Lewis acidic complex (8g) and the lowest catalytic activity observed with the most Lewis acidic complexes (8d,f). Therefore, complexes 8a–g were screened as catalysts for the synthesis of oxazolidinones 3a/4a from styrene oxide 1a and phenylisocyanate 9a as shown in Scheme 2. When catalysed by aluminium(salen) complex 5, some of the reactions shown in Scheme 1 require the use of tetrabutylammonium bromide as a cocatalyst. Therefore, the screening of vanadiumV(salen) complexes 8a–g was carried out both with and without the use of an equimolar amount of tetrabutylammonium bromide as a cocatalyst and the results are presented in Table 1.
 |
| Scheme 2 Screening of vanadiumV(salen) complexes for oxazolidinone 3a/4a synthesis. | |
Table 1 Use of complexes 8a–g as catalysts for the synthesis of oxazolidinones 3a/4aa
Entry |
Complex |
Conversionb,c (%) |
Conversionc,d (%) |
Reaction conditions: 5 mol% catalyst, 0 or 5 mol% Bu4NBr, toluene, 80 °C, 4 hours. Conversions determined by 1H NMR analysis of the reaction mixture. Without the use of Bu4NBr as cocatalyst. Figure in brackets is the ratio of 3a : 4a. With the use of Bu4NBr as cocatalyst. |
1 |
8a |
26 (1 : 1.7) |
42 (1 : 2.7) |
2 |
8b |
14 (1 : 1.3) |
55 (1 : 2.7) |
3 |
8c |
18 (1 : 1.4) |
61 (1 : 2.4) |
4 |
8d |
12 (1 : 1.3) |
90 (1 : 2.8) |
5 |
8e |
56 (1 : 1.5) |
77 (1 : 2.9) |
6 |
8f |
10 (1 : 1.3) |
90 (1 : 3.5) |
7 |
8g |
47 (1 : 1.4) |
44 (1 : 1.7) |
All of complexes 8a–g displayed some catalytic activity even in the absence of tetrabutylammonium bromide, with the nitrate (8e) and isothiocyanate (8g) complexes being the most active catalysts (Table 1, entries 5 and 7). However, the level of catalytic activity was modest, with at most 56% conversion being obtained. The addition of tetrabutylammonium bromide as a cocatalyst substantially improved the conversion in all cases except for the reaction catalysed by complex 8g (Table 1, entry 7). Under these conditions, complexes 8d and 8f both gave 90% conversion of styrene oxide into oxazolidiones 3a/4a (Table 1, entries 4 and 6).
The tetrabutylammonium bromide could perform at least two functions in these reactions: it could ring-open the epoxide, and it could react with the vanadium complexes to form complex 8c in situ. However, the catalytic activity of complex 8c was significantly increased by the addition of tetrabutylammonium bromide (Table 1, entry 3) and the activity of complexes 8d–f with tetrabutylammonium bromide were higher than that of complex 8c with tetrabutylammonium bromide (Table 1, entries 3–6). These results suggest that the principal role of the tetrabutylammonium bromide is to provide a good nucleophile (which can subsequently also be a good leaving group) to ring-open the epoxide. The two complexes which displayed the highest catalytic activity (8d,f) were those in which the counterion is a sulphate or sulphonate group. Park and coworkers have recently presented evidence that sulphonate anions can activate carbon dioxide during cyclic carbonate synthesis by formation of a mixed anhydride21 and a similar activation of the isocyanate in our system would account for the high catalytic activity displayed by complexes 8d,f. Thus the most active catalysts would be capable of activating both the epoxide (and/or the ring-opened bromo-alkoxide) and the isocyanate within the catalytic cycle.
To investigate the importance of the tetrabutylammonium anion, reactions were carried out under the conditions specified in Table 1, with complex 8d and tetrabutylammonium fluoride, chloride or iodide as cocatalyst. The use of tetrabutylammonium fluoride as cocatalyst resulted in no conversion occurring, whilst a tetrabutylammonium chloride cocatalyst gave 41% conversion to a 1
:
1.6 ratio of 3a/4a. When tetrabutylammonium iodide was used as cocatalyst, a conversion of 87% was obtained to a 1
:
1.8 ratio of 3a/4a. These results highlight the importance of a good nucleophile/leaving group in the tetrabutylammonium salt and confirm that tetrabutylammonium bromide is the optimal cocatalyst both in terms of conversion and 3a/4a ratio.
Styrene oxide is known to be an unusual substrate for epoxide ring-opening reactions as the phenyl ring favours ring-opening at the secondary carbon atom, thus giving oxazolidinone 4a as the major product. Therefore, the two most active catalysts 8d and 8f were screened with epoxides 1a–d to investigate the generality of the oxazolidinone synthesis (Scheme 3). Epoxides 1b–d were chosen to include an unfunctionalized aliphatic substrate and two functionalized epoxides. These reactions were carried out using just 1 mol% of vanadium complex and tetrabutylammonium bromide, giving the results shown in Table 2.
 |
| Scheme 3 Screening of vanadiumV(salen) complexes 8d,f for oxazolidinone 3a–d/4a–d synthesis. | |
Table 2 Use of complexes 8d,f as catalysts for the synthesis of oxazolidinones 3a–d/4a–da
Entry |
Complex |
Epoxide |
Conversionb (%) |
Reaction conditions: 1 mol% catalyst, 1 mol% Bu4NBr, toluene, 80 °C, 24 hours. Conversions determined by 1H NMR analysis of the reaction mixture. Figure in brackets is the ratio of 6 : 7. |
1 |
8d |
1a |
90 (1 : 2.8) |
2 |
8d |
1b |
52 (1 : 0) |
3 |
8d |
1c |
41 (2.3 : 1) |
4 |
8d |
1d |
58 (1 : 0) |
5 |
8f |
1a |
90 (1 : 3.5) |
6 |
8f |
1b |
42 (1 : 0) |
7 |
8f |
1c |
24 (2.3 : 1) |
8 |
8f |
1d |
49 (1 : 0) |
Styrene oxide 1a was still an excellent substrate for both catalysts under these conditions (Table 2, entries 1 and 5). The aliphatic epoxides gave lower conversions, but in each case, complex 8d was found to be a more effective catalyst than complex 8f. Therefore, subsequent reaction optimization experiments focussed on the use of complex 8d with epoxides 1b–d. Experiments were carried out to optimize the reaction time, amount of catalyst 8d, amount of tetrabutylammonium bromide and the concentration of substrates 1 and 9a. The results of this study are shown in Table 3.
Table 3 Influence of catalyst loading and substrate concentrations in the synthesis of oxazolidiones 3a–d/4a–d catalysed by complex 8da
Entry |
Epoxide (conc M) |
8d (mol%) |
Time (h) |
Conversionb (%) |
Reaction conditions: same concentration of Bu4NBr as complex 8d, same concentration of 9a as 1 unless stated otherwise, toluene, 80 °C. Conversions determined by 1H NMR analysis of the reaction mixture. Figure in brackets is the ratio of 3 : 4. 1.2 equivalents of isocyanate 9a used. |
1 |
1b (1.67) |
0.5 |
24 |
51 (1 : 0) |
2 |
1b (1.67) |
0.5 |
48 |
51 (1 : 0) |
3 |
1c (1.67) |
0.5 |
24 |
16 (4 : 1) |
4 |
1c (1.67) |
0.5 |
48 |
16 (4 : 1) |
5 |
1d (1.67) |
0.5 |
24 |
46 (1 : 0) |
6 |
1d (1.67) |
0.5 |
48 |
46 (1 : 0) |
7 |
1b (1.67) |
1.0 |
24 |
52 (1 : 0) |
8 |
1c (1.67) |
1.0 |
24 |
41 (2.33 : 1) |
9 |
1d (1.67) |
1.0 |
24 |
58 (1 : 0) |
10 |
1b (1.67) |
2.0 |
24 |
54 (1 : 0) |
11 |
1c (1.67) |
2.0 |
24 |
45 (2 : 1) |
12 |
1d (1.67) |
2.0 |
24 |
70 (1 : 0) |
13 |
1b (1.67) |
4.0 |
24 |
56 (1 : 0) |
14 |
1c (1.67) |
4.0 |
24 |
53 (1.9 : 1) |
15 |
1d (1.67) |
4.0 |
24 |
81 (1 : 0) |
16 |
1b (0.84) |
2.0 |
24 |
70 (1 : 0) |
17 |
1c (0.84) |
2.0 |
24 |
45 (2.4 : 1) |
18 |
1d (0.84) |
2.0 |
24 |
93 (1 : 0) |
19 |
1b (0.42) |
2.0 |
24 |
58 (1 : 0) |
20 |
1c (0.42) |
2.0 |
24 |
41 (2.4 : 1) |
21 |
1d (0.42) |
2.0 |
24 |
74 (1 : 0) |
22c |
1b (1.67) |
1.0 |
24 |
48 (1 : 0) |
23c |
1c (1.67) |
1.0 |
24 |
31 (3.1 : 1) |
24c |
1d (1.67) |
1.0 |
24 |
47 (1 : 0) |
The effect of varying the concentration of catalyst 8d (and tetrabutylammonium bromide) was found to be substrate dependent. Thus, for epichlorohydrin 1b, the conversion only increased from 51 to 56% as the catalyst concentration increased from 0.5 to 4 mol% (Table 3, entries 1, 7, 10 and 13). However, for epoxides 1c and 1d the effect of catalyst concentration was much more pronounced: from 16 to 53% conversion for epoxide 1c (Table 3, entries 2, 8, 11 and 14) and from 46 to 81% conversion for epoxide 1d (Table 3, entries 3, 9, 12 and 15). The influence of reaction time was also investigated for reactions catalysed by 0.5 mol% of complex 8d by leaving reactions for either 24 or 48 hours. However, for all three substrates exactly the same conversion was observed after 24 and 48 hours (Table 3, entries 1–6). Reactions involving 1-hexene oxide 1c were found to be insensitive to the substrate concentration (Table 3, entries 11, 17 and 20), whereas reactions involving substrates 1b and 1d were much more concentration dependent (Table 3, entries 10, 16, 19 and 12, 18, 21). In each case the optimal conversion was found at a substrate concentration of 0.84 M (Table 3, entries 16–18).
During these reactions, diphenyl urea was identified as a by-product arising from reaction between isocyanate 9a and adventitious water. This (rather than catalyst deactivation) was found to be the reason why the conversion did not increase when the reaction time increased from 24–48 hours. In an attempt to minimise the effect of this side reaction, reactions were carried out using 1.2 equivalents of isocyanate 9a, however, for all three substrates this resulted in a lower conversion than when exactly one equivalent of isocyanate was used (Table 3, entries 7–9 and 22–24).
Thus, the optimal conditions were determined to be the use of 2 mol% of catalyst 8d and tetrabutylammonium bromide with equimolar amounts of epoxide and isocyanate at a substrate concentration of 0.84 M at 80 °C in toluene. Although the reactions shown in Table 3 were all run for at least 24 hours, further control experiments showed that the conversion did not increase after a reaction time of just five hours. Thus, these conditions were taken as standard and applied to reactions involving eight epoxides (1a–h) and six isocyanates (9a–f) as shown in Scheme 4. These reactions were all worked up and the major isomer of the oxazolidinone (3a–r or 4a–r) isolated by flash chromatography. The results are given in Table 4.
 |
| Scheme 4 Synthesis of oxazolidinones 3a–r/4a–r. | |
Table 4 Synthesis of oxazolidinones 3a–r/4a–r catalysed by complex 8da
Entry |
Epoxide |
Isocyanate |
Conversionb (%) |
Productc (%) |
Reaction conditions: 2 mol% of 8d and Bu4NBr, [1] = [9] = 0.84 M, toluene, 80 °C, 5 hours. Conversions determined by 1H NMR analysis of the reaction mixture. Figure in brackets is the ratio of 3 : 4. Figure in brackets is the isolated chemical yield of the purified major regioisomer. |
1 |
1a |
9a |
98 (1 : 2.5) |
4a (64) |
2 |
1b |
9a |
70 (1 : 0) |
3b (68) |
3 |
1c |
9a |
46 (2.4 : 1) |
3c (29) |
4 |
1d |
9a |
93 (1 : 0) |
3d (89) |
5 |
1e |
9a |
83 (4.0 : 1) |
3e (60) |
6 |
1f |
9a |
52 (3.0 : 1) |
3f (36) |
7 |
1g |
9a |
46 (3.0 : 1) |
3g (31) |
8 |
1h |
9a |
72 (1 : 3.2) |
4h (49) |
9 |
1a |
9b |
68 (1 : 2.2) |
4i (41) |
10 |
1a |
9c |
40 (1 : 1.9) |
4j (25) |
11 |
1a |
9d |
40 (1 : 2.1) |
4k (23) |
12 |
1a |
9e |
65 (1 : 2.6) |
4l (41) |
13 |
1a |
9f |
76 (1 : 2.1) |
4m (47) |
14 |
1b |
9b |
52 (1 : 0) |
3n (44) |
15 |
1b |
9c |
34 (1 : 0) |
3o (30) |
16 |
1b |
9d |
41 (1 : 0) |
3p (40) |
17 |
1b |
9e |
63 (1 : 0) |
3q (58) |
18 |
1b |
9f |
71 (1 : 0) |
3r (69) |
Epoxides bearing an aliphatic sidechain (1c,f,g) were found to be the worst substrates under these reaction conditions, giving the lowest conversions and isolated yields of 3,5-oxazolidinones 3c,f,g (Table 4, entries 3, 6 and 7). In contrast substrates with aromatic or functionalised sidechains gave much better conversions and isolated yields (Table 4, entries 1, 2 and 4). Glycidol 1h was also a reasonably good substrate, showing that the alcohol does not inhibit the reaction by coordinating to the vanadium ion (Table 4, entry 8). For styrene oxide 1a and glycidol 1h, the 3,4-oxazolidinone 4a,h was the major isomer of the product whilst for all other substrates, the 3,5-isomer was the major product. The 3,5-isomer arises from ring-opening of the epoxide at its terminal end and is the normal product of these reactions. The electron-rich aromatic ring of styrene oxide diverts the ring-opening to the methine carbon and for glycidol, the reaction is known to follow a different pathway in which the isocyanate first reacts with the alcohol to form a urethane, which then intramolecularly ring-opens the epoxide to form an oxazolidinone, leading to the formation of the 3,4-isomer.22 The reactions of epichlorohydrin 1b and 3-phenoxypropylene oxide 1d were notable for being completely regioselective (Table 4, entries 2 and 4).
Styrene oxide 1a and epichlorohydrin 1b were then selected as representative epoxides leading to the 3,4- and 3,5-oxazolidinones respectively, and each was reacted with five substituted aromatic isocyanates (Table 4, entries 9–18). In both cases, isocyanates bearing electronically neutral (Table 4, entries 9 and 14) or electron-donating substituents (Table 4, entries 12, 13 and 17) gave better conversions and isolated yields than isocyanates bearing electron-withdrawing substituents (Table 4, entries 10, 11, 15 and 16). This may indicate that ring closure to form the oxazolidinone ring is the rate determining step of the mechanism as this would be favoured by an electron-rich substituent on the nitrogen atom. In all cases, the regiochemistry seen using phenyisocyanate was mirrored with the substituted aromatic isocyanates showing that this is determined by the nature of the epoxide and is not significantly affected by the isocyanate. The reactions of epichlorohydrin 1b were again completely regioselective (Table 4, entries 14–18). Attempts to use aliphatic isocyanates or disubstituted epoxides were unsuccessful.
To investigate the reaction mechanism, attempts were made to study the reaction kinetics. However, initial experiments indicated that catalyst decomposition was occurring during the reactions which prevented meaningful kinetic data from being acquired. Never the less, based on our previous work12–15 and the results of Park,21 a possible mechanism is shown in Scheme 5. The epoxide is first activated by coordination to the positively charged vanadiumV ion and then ring-opened by bromide provided by the teatrabutylammonium bromide counterion. Meanwhile, the sulphate or sulphonate counterion of the vanadium catalyst reacts with the isocyanate and adventitious water to form a mixed anhydride. Nucleophilic attack of the vanadium coordinated alkoxide on the carbonyl of the mixed anhydride then leads to an acyclic bromocarbamate and regeneration of the vanadium catalyst. The bromoalkoxide can finally cyclize to the oxazolidinone (in what appears to be the rate determining step), regenerating the tetrabutylammonium bromide and adventitious water. For vanadiumV(salen) complexes which do not have a sulphate or sulphonate counterion, this mechanism can be modified to have the vanadium coordinated alkoxide undergo nucleophilic attack on the unactivated isocyanate, thus explaining why such complexes are still catalytically active, but less active than catalysts which do have a sulphate or sulphonate counterion.
 |
| Scheme 5 Possible mechanism for the formation of oxazolidinones. | |
Epoxides 1a–h were all used as racemates, so even though complexes 8 are chiral no asymmetric induction was expected in reactions which progressed to high conversion and none of oxazolidinones 3/4a–r displayed any optical activity. This is consistent with previous work using aluminium based catalyst 5.14
Conclusions
VanadiumV complex 8d and tetrabutylammonium bromide form a highly active catalyst system for the synthesis of oxazolidinones from epoxides and aromatic isocyanates. Compared to the previously reported14 use of bimetallic aluminium(salen) complex 5, the catalyst loading can be reduced from 5 mol% (10 mol% of metal ions) to 2 mol% and the reaction time reduced from 24 to 5 hours. Another difference between the two systems is that the vanadium based catalyst requires the use of tetrabutylammonium bromide as a cocatalyst, whilst tetrabutylammonium bromide inhibited reactions catalysed by complex 5. The reaction mechanism appears to involve cooperative Lewis acid activation of the epoxide and nucleophilic activation of the epoxide.
Experimental
Catalysts 8a–g were prepared as previously reported.18 All other compounds were commercially available and used as supplied. 1H NMR and 13C NMR spectra were recorded in CDCl3 at 25 °C on a Bruker Avance300 spectrometer operating at 300 or 75 MHz, respectively, or on a JEOL400 spectrometer operating at 400 or 100 MHz, respectively. Chemical shifts are quoted in ppm relative to tetramethylsilane. Infrared spectra were recorded at room temperature on a Varian 800 FT-IR Scimitar series spectrometer, measuring specific absorbance intensities as: broad (br), strong (s), medium (m), or weak (w). Melting points were determined on a Stuart SMP3 system.
General procedure for the synthesis of oxazolidinones 3a–r/4a–r
To a stirred solution of complex 8a–g (8.4–41.8 μmol) and a cocatalyst (8.4–41.8 μmol) in toluene (0.5–2 ml) was added an epoxide 1a–h (0.835 mmol) and isocyanate 9a–f (0.835 mmol). The reaction was then heated to 80 °C and stirred for 5–48 hours. The reaction was cooled to room temperature and solvent removed in vacuo. CH2Cl2 (5 ml) was added to the residue and the mixture filtered through silica, washing with additional CH2Cl2 (5 ml) and the solvent was removed in vacuo. The conversion and ratio of regioisiomeric oxazolidinones was determined by 1H NMR spectroscopy, then the residue was purified as described for each compound below. The major isomers of 3a–r/4a–r are all known compounds and the spectroscopic data matched those reported in the literature.9,14
Data for 4a. Obtained as a white solid after purification by flash chromatography using CH2Cl2
:
hexane (85
:
15) as solvent. mp 128–129 °C (lit.14 128–129 °C); υmax (ATR) 3065, 2981, 2889, 1750, 1705, 1596 cm−1; δH (300 MHz, CDCl3) 7.5–7.2 (9H, m, ArH), 7.10 (1H, t J 7.4 Hz, ArH), 5.42 (1H, dd J 8.8, 6.0 Hz, CH), 4.81 (1H, t J 8.7 Hz, CH2), 4.22 (1H, dd J 8.6, 6.0 Hz, CH2); δC (75 MHz, CDCl3) 155.8, 138.6, 137.3, 129.3, 128.9, 128.8, 126.3, 124.7, 121.0, 69.8, 60.9.
Data for 3b. Obtained as a white solid after washing with Et2O. mp 104–105 °C (lit.7 104–105 °C); υmax (ATR) 3040, 2981, 2917, 1734, 1599 cm−1; δH (300 MHz, CDCl3) 7.6–7.3 (4H, m, ArH), 7.17 (1H, t J 7.4, 1.1 Hz, ArH), 4.88 (1H, dddd, J 8.7, 6.5, 5.6, 4.1 Hz, CH), 4.17 (1H, t, J 8.9 Hz, CH2N), 3.96 (1H, dd, J 9.1, 5.7 Hz, CH2N), 3.79 (1H, dd J 11.6, 4.2 Hz, CH2Cl), 3.74 (1H, dd J 11.6, 6.6 Hz, CH2Cl); δC (75 MHz, CDCl3) 153.9, 138.0, 129.1, 124.4, 118.6, 70.9, 48.3, 44.5.
Data for 3c. Obtained as a cream coloured solid after purification by flash chromatography using CH2Cl2
:
hexane (75
:
25) as solvent. mp 62–63 °C (lit.14 65–66 °C); υmax (ATR) 3064, 2981, 2930, 2880, 1741, 1703, 1597 cm−1; δH (300 MHz, CDCl3) 7.56 (2H, dd J 8.7, 1.0 Hz, ArH), 7.39 (2H, t J 8.7 Hz, ArH), 7.14 (1H, tt J 7.4, 1.2 Hz, ArH), 4.7–4.5 (1H, m, CH), 4.09 (1H, t J 8.5 Hz, CH2N), 3.66 (1H, dd J 8.8, 7.2 Hz, CH2N), 2.0–1.8 (1H, m, CH2), 1.8–1.7 (1H, m, CH2), 1.6–1.3 (4H, m, CH2CH2Me), 0.96 (3H, t J 7.2 Hz, CH3); δC (75 MHz, CDCl3) 154.9, 138.7, 129.0, 124.0, 118.4, 73.1, 50.7, 34.8, 26.7, 22.4, 13.8.
Data for 3d. Obtained as a white solid after washing with Et2O. mp 139–140 °C (lit.14 139–140 °C); υmax (ATR) 3043, 2940, 1736, 1598 cm−1; δH (300 MHz, CDCl3) 7.60 (2H, d J 7.7 Hz, ArH), 7.41 (2H, t J 8.5 Hz, ArH), 7.33 (2H, t J 7.3 Hz, ArH), 7.18 (1H, t J 7.3 Hz, ArH), 7.02 (1H, t J 7.3 Hz, ArH), 6.93 (2H, d J 7.6 Hz, ArH), 5.0–4.9 (1H, m, CH), 4.3–4.1 (3H, m, CH2O + CH2N), 4.06 (1H, dd J 8.9, 5.9 Hz, CH2N); δC (75 MHz, CDCl3) 158.3, 154.3, 138.4, 129.7, 129.1, 124.3, 122.0, 118.6, 115.0, 70.5, 68.4, 47.7.
Data for 3e. Obtained as a white solid after purification by flash chromatography using CH2Cl2
:
hexane (75
:
25) as solvent. mp 78–80 °C (lit.14 79–82 °C); υmax (ATR) 3036, 2981, 2884, 1740, 1670, 1599 cm−1; δH (300 MHz, CDCl3) 7.51 (2H, dd J 8.7, 1.0 Hz, ArH), 7.36 (2H, t J 8.1 Hz, ArH), 7.11 (1H, t J 7.4 Hz, ArH), 4.8–4.6 (1H, m, CH), 4.09 (1H, t J 8.5 Hz, CH2), 3.60 (1H, dd J 8.9, 7.1 Hz, CH2), 1.51 (3H, d J 6.3 Hz, CH3); δC (75 MHz, CDCl3) 154.9, 138.6, 129.1, 124.1, 118.5, 69.5, 52.1, 20.7.
Data for 3f9. Obtained as a colourless oil after purification by flash chromatography using CH2Cl2
:
hexane (75
:
25) as solvent. υmax (ATR) 3038, 2970, 1738, 1703, 1597 cm−1; δH (300 MHz, CDCl3) 7.57 (2H, dd J 7.4, 1.0 Hz, ArH), 7.38 (2H, t J 8.7 Hz, ArH), 7.13 (1H, t J 7.4 Hz, ArH), 4.7–4.5 (1H, m, CH), 4.07 (1H, t J 8.6 Hz, CH2), 3.65 (1H, dd J 8.8, 7.1 Hz, CH2), 2.0–1.7 (2H, m, MeCH2), 1.07 (3H, t J 7.5, CH3); δC (75 MHz, CDCl3) 154.89, 138.28, 128.91, 123.78, 118.02, 74.04, 49.94, 27.90, 8.66.
Data for 3g. Obtained as a beige coloured solid after purification by flash chromatography using CH2Cl2
:
hexane (75
:
25) as solvent. mp 71–72 °C (lit.14 70–71 °C); υmax (ATR) 2981, 2889, 1706, 1594 cm−1; δH (300 MHz, CDCl3) 7.6–7.5 (2H, m, ArH), 7.5–7.3 (2H, m, ArH), 7.14 (1H, tt J 7.3, 1.2 Hz, ArH), 4.7–4.6 (1H, m, CH), 4.07 (1H, t J 8.5 Hz, CH2N), 3.64 (1H, dd J 8.7, 7.2 Hz, CH2N), 2.0–1.8 (1H, m, CH2), 1.8–1.6 (1H, m, CH2), 1.6–1.2 (12H, m, (CH2)6Me), 0.87 (3H, t J 6.9 Hz, CH3); δC (75 MHz, CDCl3) 154.9, 138.7, 129.0, 123.9, 118.4, 73.1, 50.7, 35.1, 31.8, 29.4, 29.3, 29.1, 24.6, 22.6, 13.9.
Data for 4h. Obtained as a white solid after purification by flash chromatography using CH2Cl2 as solvent. mp 110–112 °C (lit.14 109–111 °C); υmax (ATR) 3271, 3137, 3082, 2981, 2889, 1737, 1599 cm−1; δH (300 MHz, CDCl3) 7.5–7.2 (4H, m, ArH), 7.1–6.9 (2H, m, ArH + OH), 4.58 (1H, dd J 12.2, 2.9 Hz, CH2O), 3.97 (1H, dd J 12.2, 6.5 Hz, CH2O), 3.29 (1H, ddt J 6.7, 4.1, 2.7 Hz, CHN), 2.89 (1H, t J 4.4 Hz, CH2O), 2.71 (1H, dd J 4.9, 2.6 Hz, CH2O); δC (75 MHz, CDCl3) 153.1, 137.7, 129.1, 123.8, 119.1, 65.8, 49.5, 44.6.
Data for 4i. Obtained as a cream coloured solid after purification by flash chromatography using CH2Cl2
:
hexane (85
:
15) as solvent. mp 91–92 °C (lit.14 94–97 °C); υmax (ATR) 2981, 2889, 1744, 1710, 1509 cm−1; δH (300 MHz, CDCl3) 7.4–7.2 (7H, m, ArH), 6.95 (2H, dd J 9.2, 8.3 Hz, ArH), 5.36 (1H, dd J 8.8, 6.3 Hz, CH), 4.78 (1H, t J 8.7 Hz, CH2), 4.21 (1H, dd J 8.7, 6.3 Hz, CH2); δC (75 MHz, CDCl3) 159.9 (d J 243 Hz), 156.0, 138.2, 130.3, 129.5, 126.4, 123.1 (d J 8 Hz), 116.3, 115.8 (d J 22 Hz), 69.8, 61.3.
Data for 4j. Obtained as a white solid after purification by flash chromatography using CH2Cl2
:
hexane (85
:
15) as solvent. mp 123–125 °C (lit.14 126–128 °C); υmax (ATR) 3040, 2960, 1737, 1700, 1597 cm−1; δH (300 MHz, CDCl3) 7.5–7.0 (9H, m, ArH), 5.35 (1H, dd J 8.7, 6.1 Hz, ArH), 4.77 (1H, t J 8.7 Hz, CH2), 4.20 (1H, dd, J 8.5, 6.0 Hz, CH2); δC (100 MHz, CDCl3) 155.7, 137.7, 135.5, 129.8, 129.4, 129.0, 128.9, 126.1, 121.8, 69.7, 60.5.
Data for 4k. Obtained as a yellow solid after purification by flash chromatography using CH2Cl2
:
hexane (85
:
15) as solvent. mp 136–137 °C (lit.14 134–137 °C); υmax (ATR) 2981, 2909, 1735, 1601 cm−1; δH (300 MHz, CDCl3) 7.4–7.0 (9H, m, ArH), 5.29 (1H, dd J 8.7, 6.0 Hz, CH), 4.71 (1H, t J 8.7 Hz, CH2), 4.13 (1H, dd, J 8.6, 6.0 Hz, CH2); δC (75 MHz, CDCl3) 155.5, 138.1, 136.5, 131.9, 129.5, 129.0, 126.2, 122.4, 117.7, 69.8, 60.8.
Data for 4l. Obtained as a cream coloured solid after purification by flash chromatography using CH2Cl2
:
hexane (85
:
15) as solvent. mp 103–105 °C (lit.14 105–107 °C); υmax (ATR) 2923, 1734 cm−1; δH (300 MHz, CDCl3) 7.5–7.3 (7H, m, ArH), 6.90 (2H, d J 8.4 Hz, ArH), 5.62 (1H, t J 8.4 Hz, CH), 4.34 (1H, t J 8.8 Hz, CH2), 3.92 (1H, t J 8.7 Hz, CH2), 3.79 (3H, s, OCH3); δC (75 MHz, CDCl3) 157.0, 156.2, 138.5, 130.2, 129.2, 128.7, 126.5, 123.3, 114.3, 69.6, 61.4, 55.3.
Data for 4m. Obtained as a cream coloured solid after purification by flash chromatography using CH2Cl2
:
hexane (85
:
15) as solvent. mp 104–106 °C (lit.14 105–107 °C); υmax (ATR) 3040, 2982, 2915, 1738, 1601 cm−1; δH (300 MHz, CDCl3) 7.6–7.2 (7H, m, ArH), 7.06 (2H, d J 8.3 Hz, ArH), 5.38 (1H, dd J 8.9, 6.2 Hz, CH), 4.74 (1H, t J 8.7 Hz, CH2), 4.17 (1H, dd J 8.5, 6.0 Hz, CH2), 2.25 (3H, s, ArCH3); δC (75 MHz, CDCl3) 155.9, 138.6, 134.7, 134.4, 129.4, 129.2, 128.6, 126.2, 121.2, 69.7, 60.9, 20.6.
Data for 3n. Obtained as a white solid after washing with Et2O. mp 105–106 °C (lit.14 101–104 °C); υmax (ATR) 2982, 2908, 1735 cm−1; δH (300 MHz, CDCl3) 7.52 (2H, dd J 9.2, 4.6 Hz, ArH), 7.10 (2H, dd J 9.2, 8.2 Hz, ArH), 5.0–4.8 (1H, m, CH), 4.18 (1H, t J 9.0 Hz, NCH2), 3.97 (1H, dd J 9.1, 5.7 Hz, NCH2), 3.84 (1H, dd J 11.6, 7.4 Hz, CH2Cl), 3.77 (1H, dd J 11.6, 6.4 Hz, CH2Cl); δC (75 MHz, CDCl3) 160.9, 154.0, 133.8 (d J 5.2 Hz), 120.2, 115.7 (d J 22.3 Hz), 70.4, 48.1, 44.7.
Data for 3o. Obtained as a white solid after washing with Et2O. mp 128–129 °C (lit.14 130–133 °C); υmax (ATR) 3040, 2907, 1737, 1598 cm−1; δH (300 MHz, CDCl3) 7.47 (2H, d J 9.0 Hz, ArH), 7.32 (2H, d J 9.0 Hz, ArH), 4.9–4.8 (1H, m, CH), 4.13 (1H, t J 8.9 Hz, NCH2), 3.91 (1H, dd J 9.1, 6.0 Hz, NCH2), 3.78 (1H, dd J 11.6, 4.3 Hz, CH2Cl), 3.74 (1H, dd J 11.7, 6.2 Hz, CH2Cl); δC (75 MHz, CDCl3) 153.7, 136.5, 129.6, 129.0, 119.6, 71.0, 48.1, 44.6.
Data for 3p. Obtained as a white solid after washing with Et2O. mp 126–127 °C (lit.23 125–127 °C); υmax (ATR) 3080, 2981, 2890, 1734, 1637 cm−1; δH (300 MHz, CDCl3) 7.52 (2H, d J 9.1 Hz, ArH), 7.47 (2H, d J 9.1 Hz, ArH), 5.0–4.8 (1H, m, CH), 4.17 (1H, t J 9.0 Hz, NCH2), 3.96 (1H, dd J 9.1, 5.7 Hz, NCH2), 3.83 (1H, dd J 11.6, 4.2 Hz, CH2Cl), 3.75 (1H, dd J 11.6, 6.4 Hz, CH2Cl); δC (75 MHz, CDCl3) 153.6, 137.0, 132.0, 119.9, 117.2, 70.9, 48.0, 44.5.
Data for 3q. Obtained as a white solid after washing with Et2O. mp 103–105 °C (lit.14 105–107 °C); υmax (ATR) 3030, 2973, 2904, 2841, 1731, 1598 cm−1; δH (300 MHz, CDCl3) 7.46 (2H, d J 9.1 Hz, ArH), 6.94 (2H, d J 9.1 Hz, ArH), 4.82 (1H, dq J 8.8, 5.2 Hz, CH), 4.16 (1H, t J 9.0 Hz, NCH2), 3.95 (1H, dd J 9.1, 5.7 Hz, NCH2), 3.78 (3H, s, OCH3), 3.9–3.7 (2H, m, CH2Cl); δC (75 MHz, CDCl3) 156.7, 154.1, 131.1, 120.6, 114.4, 70.9, 55.5, 48.7, 44.7.
Data for 3r. Obtained as a cream coloured solid after washing with Et2O. mp 101–103 °C (lit.14 104–107 °C); υmax (ATR) 3025, 2909, 1733, 1616 cm−1; δH (300 MHz, CDCl3) 7.44 (2H, d J 8.5 Hz, ArH), 7.21 (2H, d J 8.1 Hz, ArH), 4.86 (1H, dddd, J 8.7, 6.6, 5.7, 4.2 Hz, CH), 4.17 (1H, t J 9.0 Hz, NCH2), 3.96 (1H, dd, J 9.2, 5.7 Hz, NCH2), 3.81 (1H, dd, J 11.6, 4.2 Hz, CH2Cl), 3.75 (1H, dd, J 11.5, 6.6 Hz, CH2Cl), 2.36 (3H, s, ArCH3); δC (75 MHz, CDCl3) 154.0, 135.6, 134.3, 129.7, 118.8, 71.0, 48.6, 44.5, 20.7.
Acknowledgements
The authors thank EPSRC for a studentship to CB.
Notes and references
- For recent reviews see:
(a) A. Decortes, A. M. Castilla and A. W. Kleij, Angew. Chem., Int. Ed., 2010, 49, 9822–9837 CrossRef CAS PubMed;
(b) P. P. Pescarmona and M. Taherimehr, Catal. Sci. Technol., 2012, 2, 2169–2187 RSC;
(c) X. B. Lu and D. J. Darensbourg, Chem. Soc. Rev., 2012, 41, 1462–1484 RSC;
(d) M. North, R. Pasquale and C. Young, Green Chem., 2010, 12, 1514–1539 RSC;
(e) R. Li, X. Tong, X. Li and C. Hu, Pure Appl. Chem., 2012, 84, 621–636 CrossRef CAS;
(f) C. Whiteoak and A. W. Kleij, Synlett, 2013, 1748–1756 CAS.
- M. R. Barbachyn and C. W. Ford, Angew. Chem., Int. Ed., 2003, 42, 2010–2023 CrossRef CAS PubMed.
- W. R. Roush and R. A. James, Aust. J. Chem., 2002, 55, 141–146 CrossRef CAS.
- G. P. Speranza and W. J. Peppel, J. Org. Chem., 1958, 23, 1922–1924 CrossRef CAS.
-
(a) C. Qian and D. Zhu, Synlett, 1994, 129–130 CrossRef CAS;
(b) H.-Y. Wu, J. -C. Ding and Y.-K. Liu, J. Indian Chem. Soc., 2003, 80, 36–37 CAS;
(c) M. T. Barros and A. M. F. Phillips, Tetrahedron: Asymmetry, 2010, 21, 2746–2752 CrossRef CAS.
-
(a) L. Aroua and A. Baklouti, Synth. Commun., 2007, 37, 1935–1942 CrossRef CAS;
(b) J. E. Herweh and W. J. Kauffman, Tetrahedron Lett., 1971, 12, 809–812 CrossRef;
(c) J. E. Herweh, J. Heterocycl. Chem., 1968, 5, 687–690 CrossRef CAS;
(d) J. E. Herweh, T. A. Foglia and D. Swern, J. Org. Chem., 1968, 33, 4029–4033 CrossRef CAS;
(e) H. Siegel and H. Wittmann, Monatsh. Chem., 1982, 113, 1005–1017 CrossRef CAS.
- X. Zhang, W. Chen, C. Zhao, C. Li, X. Wu and W. Z. Chen, Synth. Commun., 2010, 40, 3654–3659 CrossRef CAS.
-
(a) A. Baba, M. Fujiwara and H. Matsuda, Tetrahedron Lett., 1986, 27, 77–80 CrossRef CAS;
(b) M. Fujiwara, A. Baba and H. Matsuda, J. Heterocycl. Chem., 1988, 25, 1351–1357 CrossRef CAS;
(c) M. Fujiwara, A. Baba and H. Matsuda, Bull. Chem. Soc. Jpn., 1990, 63, 1069–1073 CrossRef CAS.
-
(a) I. Shibata, A. Baba, H. Iwasaki and H. Matsuda, J. Org. Chem., 1986, 51, 2177–2184 CrossRef CAS;
(b) M. Fujiwara, A. Baba, Y. Tomohisa and H. Matsuda, Chem. Lett., 1986, 1963–1966 CrossRef CAS;
(c) A. Baba, K. Seki and H. Matsuda, J. Heterocycl. Chem., 1990, 27, 1925–1930 CrossRef CAS;
(d) K. Yano, N. Amishiro, A. Baba and H. Matsuda, Bull. Chem. Soc. Jpn., 1991, 64, 2661–2667 CrossRef CAS.
- For recent examples of related process for oxazolidinone synthesis from heterocumulenes see:
(a) S. Pulla, C. M. Felton, Y. Gartia, P. Ramidi and A. Ghosh, ACS Sustainable Chem. Eng., 2013, 1, 309–312 CrossRef CAS;
(b) C. Qi, J. Ye, W. Zeng and H. Jiang, Adv. Synth. Catal., 2010, 352, 1925–1933 CrossRef CAS;
(c) N. D. Ca', B. Gabriele, G. Ruffolo, L. Veltri, T. Zanetta and M. Costa, Adv. Synth. Catal., 2011, 353, 133–146 CrossRef;
(d) A.-H. Liu, R. Ma, C. Song, Z.-Z. Yang, A. Yu, Y. Cai, L.-N. He, Y.-N. Zhao, B. Yu and Q.-W. Song, Angew. Chem., Int. Ed., 2012, 51, 11306–11310 CrossRef CAS PubMed;
(e) A. C. Kathalikkattil, J. Tharun, R. Roshan, H. G. Soek and D. W. Park, Appl. Catal., A, 2012, 447–448, 107–114 CrossRef CAS;
(f) J. Seayad, A. M. Seayad, J. K. P. Ng and C. L. L. Chai, ChemCatChem, 2012, 4, 774–777 CrossRef CAS;
(g) B. Wang, E. H. M. Elageed, D. Zhang, S. Yang, S. Wu, G. Zhang and G. Gao, ChemCatChem, 2014, 6, 278–283 CrossRef CAS;
(h) M. Yoshida, T. Mizuguchi and K. Shishido, Chem.–Eur. J., 2012, 18, 15578–15581 CrossRef CAS PubMed;
(i) J. Zhao, H. Huang, C. Qi and H. Jiang, Eur. J. Org. Chem., 2012, 5665–5667 CrossRef CAS;
(j) Z. Z. Yang, L. N. He, S. Y. Peng and A. H. Liu, Green Chem., 2010, 12, 1850–1854 RSC;
(k) Z. Z. Yang, Y. N. Li, Y. Y. Wei and L. N. He, Green Chem., 2011, 13, 2351–2353 RSC;
(l) C. Phung, R. M. Ulrich, M. Ibrahim, N. T. G. Tighe, D. L. Lieberman and A. R. Pinhas, Green Chem., 2011, 13, 3224–3229 RSC;
(m) A. Ueno, Y. Kayaki and T. Ikariya, Green Chem., 2013, 15, 425–430 RSC;
(n) W. Li, D. Huang and Y. Lv, RSC Adv., 2014, 4, 17236–17244 RSC;
(o) R. A. Watile and B. M. Bhanage, Indian J. Chem., Sect. A: Inorg., Bio-inorg., Phys., Theor. Anal. Chem., 2012, 51, 1354–1360 Search PubMed;
(p) R. A. Watile, D. B. Bagal, K. M. Deshmukh, K. P. Dhake and B. M. Bhanage, J. Mol. Catal. A: Chem., 2011, 351, 196–203 CrossRef CAS;
(q) J. Paz, C. Pérez-Balado, B. Iglesias and L. Muñoz, J. Org. Chem., 2010, 75, 3037–3046 CrossRef CAS PubMed;
(r) F. Fontana, C. C. Chen and V. K. Aggarwal, Org. Lett., 2011, 13, 3454–3457 CrossRef CAS PubMed;
(s) X. Y. Dou, L. N. He and Z. Z. Yang, Synth. Commun., 2012, 42, 62–74 CrossRef CAS;
(t) X. Y. Dou, L. N. He, Z. Z. Yang and J. L. Wang, Synlett, 2010, 2159–2163 CAS;
(u) H. F. Jiang, J. W. Ye, C. R. Qi and L. B. Huang, Tetrahedron Lett., 2010, 51, 928–932 CrossRef CAS;
(v) C. Phung and A. R. Pinhas, Tetrahedron Lett., 2010, 51, 4552–4554 CrossRef CAS;
(w) Y. Wu and G. Liu, Tetrahedron Lett., 2011, 52, 6450–6452 CrossRef CAS;
(x) J. Zhao and H. Jiang, Tetrahedron Lett., 2012, 53, 6999–7002 CrossRef CAS;
(y) S. W. Foo, Y. Takada, Y. Yamazaki and S. Saito, Tetrahedron Lett., 2013, 54, 4717–4720 CrossRef CAS;
(z) L. Soldi, C. Massera, M. Costa and N. D. Ca', Tetrahedron Lett., 2014, 55, 1379–1383 CrossRef CAS.
- For other applications of complex 5 see:
(a) M. S. Taylor and E. N. Jacobsen, J. Am. Chem. Soc., 2003, 125, 11204–11205 CrossRef CAS PubMed;
(b) I. T. Raheem, S. N. Goodman and E. N. Jacobsen, J. Am. Chem. Soc., 2004, 126, 706–707 CrossRef CAS PubMed;
(c) E. P. Balskus and E. N. Jacobsen, J. Am. Chem. Soc., 2006, 128, 6810–6812 CrossRef CAS;
(d) M. S. Taylor, D. N. Zaltan, A. M. Lerchner and E. N. Jacobsen, J. Am. Chem. Soc., 2005, 127, 1313–1317 CrossRef CAS;
(e) G. M. Sammis, H. Danjo and E. N. Jacobsen, J. Am. Chem. Soc., 2004, 126, 9928–9929 CrossRef CAS PubMed;
(f) C. D. Vanderwal and E. N. Jacobsen, J. Am. Chem. Soc., 2004, 126, 14724–14725 CrossRef CAS PubMed;
(g) M. Gandelman and E. N. Jacobsen, Angew. Chem., Int. Ed., 2005, 44, 2393–2397 CrossRef CAS;
(h) T. Yue, M.-X. Wang, D.-X. Wang and J. Zhu, Angew. Chem., Int. Ed., 2008, 47, 9454–9457 CrossRef CAS PubMed;
(i) M. North and C. Williamson, Tetrahedron Lett., 2009, 50, 3249–3252 CrossRef CAS;
(j) M. North, P. Villuendas and C. Williamson, Tetrahedron, 2010, 66, 1915–1924 CrossRef CAS.
- For a review of this work see: M. North, ARKIVOC, 2012,(part (i)), 610–628 Search PubMed.
-
(a) M. North and P. Villuendas, Synlett, 2010, 623–627 CrossRef CAS;
(b) W. Clegg, R. W. Harrington, M. North and P. Villuendas, J. Org. Chem., 2010, 75, 6201–6207 CrossRef CAS PubMed.
- T. Baronsky, C. Beattie, R. W. Harrington, R. Irfan, M. North, J. G. Osende and C. Young, ACS Catal., 2013, 3, 790–797 CrossRef CAS.
- C. Beattie and M. North, Chem.–Eur. J., 2014, 20, 8182–8188 CrossRef CAS PubMed.
- C. Beattie and M. North, ChemCatChem, 2014, 6, 1252–1259 CAS.
-
(a) Y. N. Belokon', M. North and T. Parsons, Org. Lett., 2000, 2, 1617–1619 CrossRef;
(b) Y. N. Belokon', B. Green, N. S. Ikonnikov, M. North, T. Parsons and V. I. Tararov, Tetrahedron, 2001, 57, 771–779 CrossRef;
(c) Y. N. Belokon', P. Carta, A. V. Gutnov, V. Maleev, M. A. Moskalenko, L. V. Yashkina, N. S. Ikonnikov, N. V. Voskoboev, V. N. Khrustalev and M. North, Helv. Chim. Acta, 2002, 85, 3301–3312 CrossRef;
(d) M. North and M. Omedes-Pujol, Tetrahedron Lett., 2009, 50, 4452–4454 CrossRef CAS;
(e) V. Chechik, M. Conte, T. Dransfield, M. North and M. Omedes-Pujol, Chem. Commun., 2010, 46, 3372–3374 RSC.
-
(a) Y. N. Belokon', V. I. Maleev, M. North and D. L. Usanov, Chem. Commun., 2006, 4614–4616 RSC;
(b) Y. N. Belokon', W. Clegg, R. W. Harrington, V. I. Maleev, M. North, M. Omedes Pujol, D. L. Usanov and C. Young, Chem.–Eur. J., 2009, 15, 2148–2165 CrossRef PubMed;
(c) M. North, M. Omedes-Pujol and C. Williamson, Chem.–Eur. J., 2010, 16, 11367–11375 CrossRef CAS PubMed;
(d) M. North and M. Omedes-Pujol, Beilstein J. Org. Chem., 2010, 6, 1043–1055 CrossRef CAS.
- J. Blacker, L. A. Clutterbuck, M. R. Crampton, C. Grosjean and M. North, Tetrahedron: Asymmetry, 2006, 17, 1449–1456 CrossRef CAS.
- M. North and J. M. Watson, ChemCatChem, 2013, 5, 2405–2409 CrossRef CAS PubMed.
- A. C. Kathalikkattil, R. Roshan, J. Tharun, H. G. Soek, H.-S. Ryu and D.-W. Park, ChemCatChem, 2014, 6, 284–292 CrossRef CAS.
-
(a) W. J. Farrissey, Jr and A. M. Nashu, J. Heterocycl. Chem., 1970, 7, 331–333 CrossRef;
(b) W. R. Roush and M. A. Adam, J. Org. Chem., 1985, 50, 3752–3757 CrossRef CAS;
(c) P. H. J. Carlsen and H. S. H. Gautun, Tetrahedron: Asymmetry, 1995, 6, 1667–1674 CrossRef;
(d) H. Wang, I. D. Kozekov, T. M. Harris and C. J. Rizzo, J. Am. Chem. Soc., 2003, 125, 5687–5700 CrossRef CAS PubMed;
(e) J. Routier, M. Calancea, M. David, Y. Vallée and J.-N. Denis, Eur. J. Org. Chem., 2008, 5687–5691 CrossRef CAS.
- J. I. Jones, J. Chem. Soc., 1957, 2735–2743 RSC.
Footnote |
† Electronic supplementary information (ESI) available: 1H NMR data for compounds 3 and 4. See DOI: 10.1039/c4ra04427d |
|
This journal is © The Royal Society of Chemistry 2014 |
Click here to see how this site uses Cookies. View our privacy policy here.